Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 621

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 621
---
s(3) 
          (d) |     |   |       Average 
  Compensation 
 Actually Paid 
            to 
       Non-PEO 
       NEOs(4) 
           (e) |     |   |   Value of 
    Initial 
 Fixed $100 
 Investment 
      Based 
     On(5): 
        (f) |     |   | Net Loss      
 (millions)(6) 
 (g)           |   |
|:-----|:-----|:--|----------------:|:----|:--|--------------:|:----|:--|----------------:|:----|:--|--------------:|:----|:--|-------------:|:----|:--|--------------:|:----|:--|-----------:|:----|:--|:--------------|:--|
| 2024 |      | $ |       1,008,272 |     | $ |             — |     | $ |         595,045 |     | $ |             — |     | $ |      559,373 |     | $ |       240,637 |     | $ |       1.69 |     | $ | (17.1         | ) |
| 2023 |      | $ |       1,283,646 |     | $ |             — |     | $ |         344,831 |     | $ |             — |     | $ |      903,548 |     | $ |       185,598 |     | $ |       3.10 |     | $ | (14.1         | ) |
| 2022 |      | $ |       1,608,712 |     | $ |     3,211,587 |     | $ |         628,658 |     | $ |     3,744,411 |     | $ |      911,088 |     | $ |       726,340 |     | $ |       5.30 |     | $ | (63.4         | ) |

| (1) | Summary Compensation Table Total for PEO: The dollar amounts reported in each column (b) are the                                                                                                                     
 amounts of total compensation reported for Dr. Iadonato (Kineta’s Chief Executive Officer) and Dr. Peters (Kineta’s former Chief Executive Officer) for each corresponding year in the “Total” column of the Summary 
 Compensation Table.